Pro-Pharmaceuticals is recruting colorectal cancer patients for a clinical trial to determine whether the combination of DAVANAT, 5-FU, Avastin and Leucovorin can help colorectal cancer patients who are unable to tolerate intensive chemotherapy. The researchers are looking for 50 people who can receive treatment at the clinical trial site in Israel.

You can learn more about the clinical trial at the NIH's website or by contacting Aaron Lubetsky, MD at aronlub@netvision.net.il. The clinical trial identifier is NCT00388700.

To learn more about clinical trials for colon cancer, please read How to Find Clinical Trials for Colon Cancer.